Synapsoft logo
AI Insights from Disclosures
Searching...
Daehan Nupharm Co.,Ltd. 054670
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of December 2025
Daehan Nupharm Co.,Ltd. operates through segments including prescription drugs, non-reimbursed drugs (obesity and wellness injections), and animal drugs. Among its major production items, the company focuses its prescription drug capabilities on metabolic diseases such as hypertension, dyslipidemia, and diabetes, which represent chronic disease groups, as well as peptic ulcer treatments, and is continuing research and development of obesity treatments linked to diabetes while expanding its scope to dementia and Parkinson's disease.
Representative Director Lee Wonseok
Founded October 20, 1984
Corporation Type KOSDAQ
Industry Classification Manufacture of medicaments
Corporate number 11011-0383515
Business number 229-81-10729
Phone Number 031-778-2600
Fax Number 02-581-1644
Website www.dhnp.co.kr
Company Address 66 Jeyakgongdan 1-gil, Hyangnam-eup, Manse-gu, Hwaseong-si, Gyeonggi-do
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant